share_log
Breakings ·  May 24 04:05
Supernus Announces Promising Interim Data From Ongoing Open-Label Phase 2a Study of Spn-817 in Epilepsy
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment